Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B
- PMID: 19017985
- PMCID: PMC2650505
- DOI: 10.4049/jimmunol.181.11.7944
Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B
Abstract
Recovery from acute hepatitis B virus (HBV) infection occurs in 95% of adult-acquired infections. A 32-bp deletion in CCR5 (CCR5Delta32), which encodes for a nonfunctional receptor, increases the likelihood of recovery. Using 181 subjects with persistent HBV infection and 316 who had recovered, we tested the hypothesis that an epistatic interaction between functional polymorphisms in RANTES (a CCR5 ligand) and CCR5 impacts recovery. Specific models designed to assess individual contributions of compound genotypes demonstrated that the only combination associated with recovery from an HBV infection was RANTES -403A with CCR5Delta32 (odds ratio 0.36, p = 0.02). Because the phenotypic consequence of -403A is reported to be higher levels of RANTES, we propose a model in which excess RANTES in combination with low CCR5 favors recovery from an HBV infection, which will require validation through functional testing.
Figures
References
-
- Lee WM. Hepatitis B virus infection. N.Engl.J.Med. 1997;337:1733–1745. - PubMed
-
- Wong MM, Fish EN. Chemokines: attractive mediators of the immune response. Semin.Immunol. 2003;15:5–14. - PubMed
-
- Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367–377. - PubMed
-
- Thio CL, Astemborski J, Bashirova A, Mosbruger T, Greer S, Witt MD, Goedert JJ, Hilgartner M, Majeske A, O'Brien SJ, Thomas DL, Carrington M. Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence. J Virol. 2007;81:441–445. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UO1-AI-35042/AI/NIAID NIH HHS/United States
- UO1-AI-35040/AI/NIAID NIH HHS/United States
- 01-HD-4-1224/HD/NICHD NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- MO1-RR00071/RR/NCRR NIH HHS/United States
- N01-HD-4-3200/HD/NICHD NIH HHS/United States
- N01 CO012400/CA/NCI NIH HHS/United States
- N02 CP055504/CP/NCI NIH HHS/United States
- UO1-AI-35039/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- 5-MO1-RR-00722/RR/NCRR NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- K08 DA000441/DA/NIDA NIH HHS/United States
- U01 AI035042/AI/NIAID NIH HHS/United States
- DA00441/DA/NIDA NIH HHS/United States
- U01 AI037984/AI/NIAID NIH HHS/United States
- UO1-AI-37984/AI/NIAID NIH HHS/United States
- MO1-RR02558/RR/NCRR NIH HHS/United States
- MO1-RR00059/RR/NCRR NIH HHS/United States
- U01 AI037613/AI/NIAID NIH HHS/United States
- UO1-AI-35041/AI/NIAID NIH HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- M01 RR000059/RR/NCRR NIH HHS/United States
- M01 RR000722/RR/NCRR NIH HHS/United States
- Z01 DA000441/ImNIH/Intramural NIH HHS/United States
- M01 RR002558/RR/NCRR NIH HHS/United States
- U01 AI035043/AI/NIAID NIH HHS/United States
- N01 CO012400/CO/NCI NIH HHS/United States
- N01-CO-12400/CO/NCI NIH HHS/United States
- MO1-RR06020/RR/NCRR NIH HHS/United States
- UO1-AI-35043/AI/NIAID NIH HHS/United States
- UO1-AI-37613/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
